id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0500-0009,FDA,FDA-2008-N-0500,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; General Licensing
Provisions; Requirements on Content and Format of Labeling for Human
Prescription Drug and Biological Products",Notice,30 Day Proposed Information Collection,2018-11-21T05:00:00Z,2018,11,2018-11-21T05:00:00Z,2018-12-22T04:59:59Z,2018-11-21T13:19:42Z,2018-25352,0,0,09000064838f1a72
FDA-2008-N-0500-0006,FDA,FDA-2008-N-0500,Agency Information Collection Activities; Proposed Collection; Comment Request; Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products,Notice,60 Day Proposed Information Collection,2018-07-20T04:00:00Z,2018,7,2018-07-20T04:00:00Z,2018-09-19T03:59:59Z,2018-09-19T01:06:35Z,2018-15512,0,0,09000064835263c7